Not currently recruiting at UCSD
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Summary
- Eligibility
- for people ages 50 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT03683251
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated